Therefore, if LACV were to evolve an additional mechanism of IFN antagonism to work synergistically with the current mechanism of LACV NSs the result could lead to higher risk of neurological disease by allowing more efficient peripheral replication and/or more severe neurological disease once LACV has reached the CNS. This evidence concerns the gene IFNA1 and nervous system disorder.